Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

176

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N06AX16	VENLAX XR 150	G	Venlafaxine HCl - 150mg	150mg	Capsule, extended release	1,416,794 L.L
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	383,955 L.L
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	575,933 L.L
N06AX16	VENLAX XR 75	G	Venlafaxine HCl - 75mg	75mg	Capsule, extended release	895,895 L.L
N06AX16	VENLAX XR 75	G	Venlafaxine HCl - 75mg	75mg	Capsule, extended release	1,343,843 L.L
B03AC	VENOFER I.V.	B	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable concentrated solution	3,594,779 L.L
C05CA05	VENOSMIL	G	Hidrosmin - 200mg	200mg	Capsule	976,973 L.L
C05CA05	VENOSMIL	G	Hidrosmin - 2%	2%	Gel	588,603 L.L
R03AC02	VENTOLIN	B	Salbutamol (sulfate) - 5mg/ml	5mg/ml	Solution	403,153 L.L
R03AC02	VENTOLIN EVOHALER	B	Salbutamol (sulfate) - 100mcg/dose	100mcg/dose	Inhalation aerosol metered dose	260,705 L.L
J01DD04	VERACOL	G	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	454,219 L.L
G04BE09	VERDA	G	Vardenafil (HCl) - 10mg	10mg	Tablet, orally disintegrating	1,023,880 L.L
P02CB01	VERMIFUGE	G	Piperazine citrate - 1g/5ml	1g/5ml	Syrup	148,463 L.L
P02CA01	VERMOX	B	Mebendazole - 100mg/5ml	100mg/5ml	Suspension	223,078 L.L
P02CA01	VERMOX	B	Mebendazole - 500mg	500mg	Tablet	106,164 L.L
P02CA01	VERMOX	B	Mebendazole - 100mg	100mg	Tablet	190,826 L.L
D02AF	VERRUFILM	G	Lactic acid - 16.7%, Salicylic acid - 16.7%		Solution	861,403 L.L
D11AF	VERRUMAL	B	Fluorouracil - 0.5g/100g, Salicylic acid - 10g/100g		Solution	529,474 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	13,085,712 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	2,772,347 L.L
N07CA01	VERTINEX	G	Betahistine dihydrochloride - 16mg	16mg	Tablet, scored	1,204,339 L.L
N07CA01	VERTINEX	G	Betahistine dihydrochloride - 16mg	16mg	Tablet	371,157 L.L
N07CA01	VERTINEX	G	Betahistine dihydrochloride - 24mg	24mg	Tablet, scored	921,492 L.L
L01EF03	VERZENIO	B	Abemaciclib - 150mg	150mg	Tablet	76,122,299 L.L
L01EF03	VERZENIO	B	Abemaciclib - 50mg	50mg	Tablet	76,122,299 L.L
L01EF03	VERZENIO	B	Abemaciclib - 100mg	100mg	Tablet	76,122,299 L.L
G04BD08	VESICARE	B	Solifenacin succinate - 5mg	5mg	Tablet, film coated	1,619,330 L.L
G04BD08	VESICARE	B	Solifenacin succinate - 10mg	10mg	Tablet, film coated	1,619,330 L.L
G04CA53	VESOMNI	B	Tamsulosin HCl - 0.4mg, Solifenacin succinate - 6mg		Tablet, modified release	4,491,122 L.L
B01AB11	VESSEL DUE F TAB.	B	Sulodexide - 250LRU	250LSU	Capsule, soft gelatin	2,792,505 L.L

...

176

...